Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use
Status:
Terminated
Trial end date:
2019-10-18
Target enrollment:
Participant gender:
Summary
G-CSF causes a release of histamine that may be a cause of chronic bone pain. Loratadine
targets histamine, and so may be effective in reducing bone pain.The researchers plan to
prospectively assess the effectiveness of loratadine for chronic bone pain in patients with
chronic G-CSF use.